scispace - formally typeset
T

Tom D. Heightman

Researcher at Astex

Publications -  66
Citations -  6609

Tom D. Heightman is an academic researcher from Astex. The author has contributed to research in topics: Histone & Bromodomain. The author has an hindex of 29, co-authored 65 publications receiving 5639 citations. Previous affiliations of Tom D. Heightman include University of Oxford & GlaxoSmithKline.

Papers
More filters
Journal ArticleDOI

Selective inhibition of BET bromodomains.

TL;DR: A cell-permeable small molecule (JQ1) that binds competitively to acetyl-lysine recognition motifs, or bromodomains is reported, establishing proof-of-concept for targeting protein–protein interactions of epigenetic ‘readers’, and providing a versatile chemical scaffold for the development of chemical probes more broadly throughout the b romodomain family.
Journal ArticleDOI

BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones

TL;DR: It is shown that BRD4 occupies widespread genomic regions in mouse cells and directly stimulates elongation of both protein-coding transcripts and noncoding enhancer RNAs (eRNAs), in a manner dependent on bromodomain function.
Journal ArticleDOI

3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.

TL;DR: Using X-ray crystallographic analysis, the interactions responsible for the activity and selectivity of 4-substituted 3,5-dimethylisoxazoles against a selection of phylogenetically diverse bromodomains are determined and compound 4d is developed, which has IC50 values of <5 μM for the b romodomain-containing proteins BRD2(1) and BRD4(1).
Journal ArticleDOI

Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras.

TL;DR: It is shown here that the hetero-bifunctional molecule can be formed intracellularly by bio-orthogonal click combination of two smaller precursors, and expected this approach to be readily extendable to other inhibitor-protein systems because the tagged E3 ligase recruiter is capable of undergoing the click reaction with a suitably tagged ligand of any protein of interest to elicit its degradation.
Journal ArticleDOI

Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors.

TL;DR: It is demonstrated that diverse compound screening can yield novel inhibitors of 2OG dependent histone demethylases and provide starting points for the development of potent and selective agents to interrogate epigenetic regulation.